Russia passed the procedure of registration of the second drug for the treatment of complications of novel coronavirus infection. The press service of the Ministry of health reported that the drug “Levelmap”, realized under the trade name “Elzira”, received a registration certificate.
the New drug is indicated for patients with severe disease develops when one of the complications COVID-19 — the so-called cytokine storm, which causes damage to tissues and organs, in particular lung tissue, there are deaths.
last week, Russia had issued the first certificate of registration of the domestic product “Avidavit”. Manufacturers claim that while using drugs the symptoms of coronavirus are leaving twice as fast. This drug will be issued free of charge.